Serum apelin is associated with affective disorders in peritoneal dialysis patients

References

• Park HC, Lee H, Lee JP, et al. Lower residual renal function is a risk factor for depression and impaired health-related quality of life in Korean peritoneal dialysis patients. J Korean Med Sci. 2012;27:64–71.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107.
   PubMed Web of Science ®Google Scholar
• Penkower L, Dew MA, Ellis D, Sereika SM, Kitutu JM, Shapiro R. Psychological distress and adherence to the medical regimen among adolescent renal transplant recipients. Am J Transplant. 2003;3:1418–1425.
   PubMed Web of Science ®Google Scholar
• Troidle L, Wuerth D, Finkelstein S, Kliger A, Finkelstein F. The BDI and the SF36: Which tool to use to screen for depression? Adv Perit Dial. 2003;19:159–162.
   PubMedGoogle Scholar
• Halen NV, Cukor D, Constantiner M, Kimmel PL. Depression and mortality in end-stage renal disease. Curr Psychiatry Rep. 2012;14:36–44.
   PubMed Web of Science ®Google Scholar
• Newson MJ, Pope GR, Roberts EM, Lolait SJ, O'Carroll AM. Stress-dependent and gender-specific neuroregulatory roles of the apelin receptor in the hypothalamic-pituitary-adrenal axis response to acute stress. J Endocrinol. 2013;216:99–109.
   PubMed Web of Science ®Google Scholar
• Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 2000;74:34–41.
   PubMed Web of Science ®Google Scholar
• Mesmin C, Fenaille F, Becher F, Tabet JC, Ezan E. Identification and characterization of apelin peptides in bovine colostrum and milk by liquid chromatography-mass spectrometry. J Proteome Res. 2011;10:5222–5231.
   PubMed Web of Science ®Google Scholar
• O'Carroll AM, Lolait SJ, Harris LE, Pope GR. The apelin receptor APJ: Journey from an orphan to a multifaceted regulator of homeostasis. J Endocrinol. 2013;219:R13–R35.
   PubMed Web of Science ®Google Scholar
• Fox SE. The functions of the limbic system. In: Greger R, Windhorst U, eds. Comprehensive Human Physiology: From Cellular Mechanisms to Integration. Germany: Springer; 1996:355–374.
   Google Scholar
• Reaux A, De Mota N, Skultetyova I, et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem. 2001;77:1085–1096.
   PubMed Web of Science ®Google Scholar
• Lv SY, Qin YJ, Wang HT, Xu N, Yang YJ, Chen Q. Centrally administered apelin-13 induces depression-like behavior in mice. Brain Res Bull. 2012;88:574–580.
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
   PubMed Web of Science ®Google Scholar
• Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol. 1988;56:893–897.
   PubMed Web of Science ®Google Scholar
• Sacks CR, Peterson RA, Kimmel PL. Perception of illness and depression in chronic renal disease. Am J Kidney Dis. 1990;15:31–39.
   PubMed Web of Science ®Google Scholar
• Guney I, Solak Y, Atalay H, et al. Comparison of effects of automated peritoneal dialysis and continuous ambulatory peritoneal dialysis on health-related quality of life, sleep quality, and depression. Hemodial Int. 2010;14:515–522.
   PubMed Web of Science ®Google Scholar
• Wuerth D, Finkelstein SH, Ciarcia J, Peterson R, Kliger AS, Finkelstein FO. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis. 2001;37:1011–1017.
   PubMed Web of Science ®Google Scholar
• Dong J, Pi HC, Xiong ZY, et al. Depression and Cognitive Impairment in Peritoneal Dialysis: A Multicenter Cross-sectional Study. Am J Kidney Dis. 2016; 67:111–118.
   PubMed Web of Science ®Google Scholar
• Martínez-Sanchis S, Bernal MC, Montagud JV, Abad A, Crespo J, Pallardó LM. Quality of life and stressors in patients with chronic kidney disease depending on treatment. Span J Psychol. 2015;18:E25.
   PubMed Web of Science ®Google Scholar
• Kutner NG, Fair PL, Kutner MH. Assessing depression and anxiety in chronic dialysis patients. J Psychosom Res. 1985;29:23–31.
   PubMed Web of Science ®Google Scholar
• Pop-Jordanova ND, Polenakovic MH. Psychological characteristics of patients treated by chronic maintenance hemodialysis. Int J Artif Organs. 2013;36:77–86.
   PubMed Web of Science ®Google Scholar
• Bossola M, Ciciarelli C, Di Stasio E, et al. Symptoms of depression and anxiety over time in chronic hemodialysis patients. J Nephrol. 2012;25:689–698.
   PubMed Web of Science ®Google Scholar
• Cukor D, Coplan J, Brown C, et al. Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol. 2007;2:484–490.
   PubMed Web of Science ®Google Scholar
• Patel A. Review: The role of inflammation in depression. Psychiatr Danub. 2013;2:216–223.
   Google Scholar
• Zeugmann S, Quante A, Heuser I, Schwarzer R, Anghelescu I. Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome. J Clin Psychiatry. 2010;71:1007–1016.
   PubMed Web of Science ®Google Scholar
• Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1044–1053.
   PubMed Web of Science ®Google Scholar
• Kalender B, Ozdemir AC, Koroglu G. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract. 2006;102:c115–c121.
   PubMedGoogle Scholar
• Ko GJ, Kim MG, Yu YM, Jo SK, Cho WY, Kim HK. Association between depression symptoms with inflammation and cardiovascular risk factors in patients undergoing peritoneal dialysis. Nephron Clin Pract. 2010;116:c29–c35.
   PubMedGoogle Scholar
• Li ZJ, An X, Mao HP, et al. Association between depression and malnutrition-inflammation complex syndrome in patients with continuous ambulatory peritoneal dialysis. Int Urol Nephrol. 2011;43:875–882.
   PubMed Web of Science ®Google Scholar
• Boulware LE, Liu Y, Fink NE, et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: Contribution of reverse causality. Clin J Am Soc Nephrol. 2006;1:496–504.
   PubMed Web of Science ®Google Scholar
• Kalender B, Dervisoglu E, Sengul E, et al. Depression, nutritional status, and serum cytokines in peritoneal dialysis patients: Is there a relationship? Perit Dial Int. 2007;27:593–595.
   PubMed Web of Science ®Google Scholar
• Chilcot J, Davenport A, Wellsted D, Firth J, Farrington K. An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant. 2011;26:1628–1634.
   PubMed Web of Science ®Google Scholar
• Preljevic VT, Østhus TB, Sandvik L, et al. Psychiatric disorders, body mass index and C-reactive protein in dialysis patients. Gen Hosp Psychiatry. 2011;33:454–461.
   PubMed Web of Science ®Google Scholar
• Dogan E, Erkoc R, Eryonucu B, Sayarlioglu H, Agargun MY. Relation between depression, some laboratory parameters, and quality of life in hemodialysis patients. Ren Fail. 2005;27:695–699.
   PubMed Web of Science ®Google Scholar
• Małyszko J, Małyszko JS, Koźminski P, Myśliwiec M. Apelin and cardiac function in hemodialyzed patients: Possible relations? Am J Nephrol. 2006;26:121–126.
   PubMed Web of Science ®Google Scholar
• Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005;107:198–211.
   PubMed Web of Science ®Google Scholar
• De Mota N, Reaux-Le Goazigo A, El Messari S, et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci U S A. 2004;101:10464–10469.
   PubMed Web of Science ®Google Scholar
• Szokodi I, Tavi P, Foldes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res. 2002;91:434–440.
   PubMed Web of Science ®Google Scholar
• Weir RA, Chong KS, Dalzell JR, et al. Plasma apelin concentration is depressed following acute myocardial infarction in man. Eur J Heart Fail. 2009;11:551–558.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen J, Bai B, Du H, Liu Y, Liu H. Heterodimerization of human apelin and kappa opioid receptors: Roles in signal transduction. Cell Signal. 2012;24:991–1001.
   PubMed Web of Science ®Google Scholar
• Carlezon WA, Jr, Béguin C, DiNieri JA, et al. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther. 2006;316:440–447.
   PubMed Web of Science ®Google Scholar
• Wadenberg ML. A review of the properties of spiradoline: A potent and selective kappa-opioid receptor agonist . CNS Drug Rev. 2003;9:187–198.
   PubMedGoogle Scholar
• Yu S, Zhang Y, Li MZ, et al. Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients. Chin Med J (Engl). 2012;125:3440–3444.
   PubMed Web of Science ®Google Scholar
• García-Díaz D, Campión J, Milagro FI, Martínez JA. Adiposity dependent apelin gene expression: Relationships with oxidative and inflammation markers. Mol Cell Biochem. 2007;305:87–94.
   PubMed Web of Science ®Google Scholar
• Fernandez M. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension. J Hepatol. 2009;50:296–305.
   PubMed Web of Science ®Google Scholar